Genome Editing of Human Embryo: Allow or Prohibit?
Abstract
Nowadays, the direction of both law-enforcement activity and dynamically developing statutory regulation is to involve genes and genetic constructions into civil-law transactions. However, the evaluation of such processes is complex within the scope of doctrine and law-enforcement.
The article aims to uncover the issues of statutory regulation within genome editing activity of human embryo in Russia. The critical analysis underlines the proposals to prohibit the genome editing of human embryo due to its low efficacy, complexity of it actual maintenance via the existing legal remedy and mechanisms. There is a presentation of legal course developments within the genome editing of human embryo together with existing risks consideration for such kind of activity.
References
[2] The Chinese scientist who edited the genes of human embryos disappeared. Profile. 6.12.2018
[3] Kolenov, S. 2019. Bioethic Kevin Smith: Our genome is not perfect. It's time to fix it. https://hightech.plus/2019/11/20/bioetik-kevin-smit-nash-genom-ne-idealen-prishlo-vremya-ispravit-ego.
[4] Kopylov, S.M. 2015. The precautionary principle in international environmental law: from its inception to the modern state. Actual problems of modern international law: Materials of the XII annual international scientific and practical conference dedicated to the memory of prof. I.P. Blishchenko. A.KhAbashidze. RUDN, 416-421.
[5] Levushkin, A.N. 2019. Unborn children: taking into account interests and rights in civil circulation and medical practice. Laws of Russia: experience, analysis, practice. № 6, 18-23.
[6] Levushkin, A.N. 2019. Civil regulation and development of family business as a type of social entrepreneurship in the Russian Federation. Civil law. № 2, 8.
[7] Levushkin, A.N. 2019. Civil legal regime of genes as objects of civil rights. Lex russica. № 6, 100 - 109.
[8] Levushkin, A.N. 2019. Civil regulation of genomic technologies and the turnover of genes as objects of civil rights. Civil Law. №5, 26-29.
[9] Levushkin, A.N., Biryukova, E.G. 2018. Quality of medical services: an intersectoral integrated approach to legal regulation. Journal of Entrepreneurial and Corporate Law. № 3, 28 - 33.
[10] McConnell, K.R., Bru, S.L. 1992. Economics: principles, problems and politics. M.: Republic, V. 2, 400.
[11] Medical and legal aspects of the safety of medicines and patients. 2017. Izhevsk:, 299.
[12] Mokhov., A.A. 2019. An unborn child - the subject of legal relations? Family and housing law. № 4, 14-18.
[13] Mokhov, A.A., Butnaru, D.V., Yavorsky, A.N. 2019. Editing the genome of the human embryo: legal aspect. Education and Law. № 1, 223-230.
[14] Mokhov, A.A., Chaplenko, A.A., Yavorsky, A.N. 2019. The use of genomic editing technologies: achievements and prospects. Biomedicine. Vol. 15. №. 2, 34-42.
[15] Mokhov, A.A. 2019. Cases on preventing harm in the future (on the example of genomic research and putting their results into practice). Bulletin of the civil process, № 2, 105 - 120.
[16] Mokhov, A.A., Yavorsky, A.N. 2018. Genes and other formations based on genes as objects of intellectual property law. Civil Law, №. 4, 32.
[17] A frustrated Russian scientist aggravates plans for creating edited children. https://www.sciencemag.org/news/2019/10/embattled-russian-scientist-sharpens-plans-create-gene-edited-babies.
[18] Salkova, A. 2019. Weave and rewrite: a new method for editing the genome has been created. Newspaper.ru.
[19] Sergeev, Yu.D., Mokhov, A.A., Yavorsky, A.N. 2019. Pilot (experimental) legal regime for domestic biomedical science and practice. Medical Law, № 4, 3 - 13.
[20] Sokolova, N.A. 2010. International legal principles of sustainable development. Eurasian Law Journal, №. 8, 35-42.
[21] Yudin, B.G. 2016. Editing a person. Man. №. 3, 5-19.
[22] Yakovlev, V.F. 1972. Civil-law method of regulation of public relations: Author. diss ... Dr. jur. sciences. Sverdlovsk, 39.
[23] Grunwald, A. 2012. Responsible Innovation: Neuer Ansatz der Gestaltung von Technik und Innovation odernurein Schlagwort? Theorie und Praxis von Technology Governance (Hrsg. S. Broschler und andere). Wien: ITA, 11-24.
[24] Hood, L. 2002. A Personal View of Molecular Technology and How It Has Changed Biology. J. Proteome Research.
[25] Hood, L, Auffray, C. 2013.Participatory medicine: a driving force for revolutionizing healthcare. Genome medicine.
The Copyright Transfer Form to ASERS Publishing (The Publisher)
This form refers to the manuscript, which an author(s) was accepted for publication and was signed by all the authors.
The undersigned Author(s) of the above-mentioned Paper here transfer any and all copyright-rights in and to The Paper to The Publisher. The Author(s) warrants that The Paper is based on their original work and that the undersigned has the power and authority to make and execute this assignment. It is the author's responsibility to obtain written permission to quote material that has been previously published in any form. The Publisher recognizes the retained rights noted below and grants to the above authors and employers for whom the work performed royalty-free permission to reuse their materials below. Authors may reuse all or portions of the above Paper in other works, excepting the publication of the paper in the same form. Authors may reproduce or authorize others to reproduce the above Paper for the Author's personal use or for internal company use, provided that the source and The Publisher copyright notice are mentioned, that the copies are not used in any way that implies The Publisher endorsement of a product or service of an employer, and that the copies are not offered for sale as such. Authors are permitted to grant third party requests for reprinting, republishing or other types of reuse. The Authors may make limited distribution of all or portions of the above Paper prior to publication if they inform The Publisher of the nature and extent of such limited distribution prior there to. Authors retain all proprietary rights in any process, procedure, or article of manufacture described in The Paper. This agreement becomes null and void if and only if the above paper is not accepted and published by The Publisher, or is with drawn by the author(s) before acceptance by the Publisher.